Pair Name | Amentoflavone, Cisplatin | ||
Phytochemical Name | Amentoflavone (PubChem CID: 5281600 ) | ||
Anticancer drug Name | Cisplatin (PubChem CID: 5702198 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Amentoflavone, Cisplatin | |||
Disease Info | [ICD-11: 2B66.0] | Oral squamous cell carcinoma | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Up-regulation | Expression | BAK1 | hsa578 |
Up-regulation | Expression | BAX | hsa581 | |
Up-regulation | Cleavage | CASP3 | hsa836 | |
Up-regulation | Cleavage | CASP9 | hsa842 | |
Down-regulation | Activity | NFKB1 | hsa4790 | |
Down-regulation | Activity | RELA | hsa5970 | |
In Vitro Model | SAS | Tongue squamous cell carcinoma | Homo sapiens (Human) | CVCL_1675 |
Result | Inactivation of NF-κB and induction of apoptosis through intrinsic caspase-dependent and independent apoptotic pathways are associated with amentoflavone enhanced anti-OSCC efficacy of cisplatin. |
No. | Title | Href |
---|---|---|
1 | Anticancer Efficacy and Mechanism of Amentoflavone for Sensitizing Oral Squamous Cell Carcinoma to Cisplatin. Anticancer Res. 2020 Dec;40(12):6723-6732. doi: 10.21873/anticanres.14695. | Click |